Armistice Capital, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $6.51 Billion distributed in 332 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ptc Therapeutics, Inc. with a value of $201M, Immunovant, Inc. with a value of $161M, Travere Therapeutics, Inc. with a value of $161M, Supernus Pharmaceuticals, Inc. with a value of $136M, and Incyte Corp with a value of $99M.
Examining the 13F form we can see an increase of $798M in the current position value, from $5.71B to 6.51B.
Armistice Capital, LLC is based out at New York, NY
Below you can find more details about Armistice Capital, LLC portfolio as well as his latest detailed transactions.
